EARNEST Partners
IMMU

EARNEST Partners’s Immunomedics Inc IMMU Stock Holding History

EARNEST Partners’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-113
Closed -$10K – 1209
2020
Q3 		$10K Buy
+113
New +$5.71K ﹤0.01% 579

EARNEST Partners's IMMU Position: Q4 2020 in Review

EARNEST Partners sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 113 shares — an estimated $10K sold.

EARNEST Partners first reported a position in IMMU in Q3 2020 and held it in 1 quarter. The position peaked at $10K in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • EARNEST Partners reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • EARNEST Partners sold 113 Immunomedics Inc shares in Q4 2020, an estimated $10K.
  • EARNEST Partners first reported a position in Immunomedics Inc in Q3 2020 and held it in 1 quarter.
  • EARNEST Partners's Immunomedics Inc position peaked at $10K in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on EARNEST Partners's 13F filing for Q4 2020, filed 16 Feb 2021.